Robert Rosenblatt
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.
Journal: Scandinavian journal of urology
Published: January 22, 2020
Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy.
Journal: World journal of urology
Published: July 08, 2019
Tumour-associated B cells in urothelial urinary bladder cancer.
Journal: Scandinavian journal of immunology
Published: April 24, 2019
Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness.
Journal: Cancer immunology research
Published: August 25, 2017
Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 14, 2016
Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.
Journal: British journal of cancer
Published: June 23, 2016
Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report.
Journal: World journal of urology
Published: May 25, 2016
Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.
Journal: Urologic oncology
Published: January 22, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026